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KV10.1 is a potassium channel expressed in brain and implicated in tumor progression. We have
searched for proteins interacting with KV10.1 and identiﬁed Rabaptin-5, an effector of the Rab5
GTPase. Both proteins co-localize on large early endosomes induced by Rab5 hyperactivity. Silencing
of Rabaptin-5 induces down-regulation of recycling of KV10.1 channel in transfected cells and
reduction of KV10.1 current density in cells natively expressing KV10.1, indicating a role of Rabap-
tin-5 in channel trafﬁcking. KV10.1 co-localizes, but does not physically interact, with Rab7 and
Rab11. Our data highlights the complex control of the amount of KV10.1 channels on the cell surface.
Structured summary of protein interactions:
Rabaptin-5 physically interacts with Kv10.1 by anti bait coimmunoprecipitation (View interaction)
Rabaptin-5 physically interacts with Rabaptin-5 by two hybrid (View interaction)
Kv10.1 physically interacts with Kv10.1 by two hybrid (View interaction)
Kv10.1 physically interacts with Rabaptin-5 by anti bait coimmunoprecipitation (View Interaction: 1, 2)
RAB11 and Kv10.1 colocalize by ﬂuorescence microscopy (View interaction)
Kv10.1 and Rabaptin-5 colocalize by ﬂuorescence microscopy (View interaction)
Kv10.1 physically interacts with Rabaptin-5 by two hybrid (View Interaction: 1, 2)
Kv10.1 and RAB7 colocalize by ﬂuorescence microscopy (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Ether à go-go (Eag1, KV10.1) is a voltage-gated potassium chan-
nel natively expressed in brain [1], where it likely participates in
controlling excitability. Additionally, KV10.1 has been implicated
in cell-cycle regulation and cancer [2,3]. In tumors, KV10.1 seems
to interfere with oxygen homeostasis, thereby increasing tumor
vascularization [4]. Nonetheless, the physiological role(s) of
KV10.1 is still unclear.
Identiﬁcation of interacting partners is key in understanding
protein function; therefore, we embarked on identifying KV10.1-
interacting protein(s) using a yeast two-hybrid system. A cDNAchemical Societies. Published by E
ax-Planck-Institute of Exper-
gen, Germany. Fax: +49 551
rg August University Medical
umology, Translational Cardi-
gen, Germany.clone coding for Rabaptin-5 (RABEP1) was positively identiﬁed as
a KV10.1 binding partner. Rabaptin-5 is a member of the large
Rab protein family [5]. Rabaptin-5 speciﬁcally interacts with the
GTP-bound form of the small GTPase Rab5 [6], which is an essen-
tial and rate-limiting component of early endosomal fusion [6]. It
also interacts with several other proteins: Rabex5 [7], tuberin [8]
or GAP-43 [9], all participating in endocytosis. It also forms a com-
plex with c1-adaptin [10] and Rab4 [11] regulating membrane
recycling [12,13]. HIF-1 down-regulation of Rabaptin-5 at the tran-
scriptional level causes deceleration in endocytosis due to the
attenuation of early endosome fusion [14].
Although it has been shown that KV10.1 interacts with Epsin, a
protein involved in endocytosis [15,16], little is known about the
mechanisms that regulate trafﬁcking of KV10.1 channels into and
out of the plasma membrane. Given the multifunctionality of
Rabaptin-5, such as binding to the Rab5 protein, involved in
endocytosis, and interaction with Rab4, involved in membrane
recycling, KV10.1-Rabaptin-5 interaction suggests a role in
determining KV 10.1 channel surface expression and internalization
fate.lsevier B.V. All rights reserved.
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2.1. Yeast two-hybrid analysis
pLexN-C-KV10.1 (bait) was generated by PCR ampliﬁcation of
the C-terminus of human KV10.1 (residues 478–963). pVP16–3-
cDNA is a postnatal day 8 rat brain library [17]. The yeast repor-
ter strain L40 [18], was transformed with pLexN-C-KV10.1 and
grown on synthetic medium. The resulting transformants were
retransformed with pVP16–3-cDNA. Positive colonies were se-
lected and tested for b-galactosidase activity. Yeast retransforma-
tion and DNA sequencing was used to further analyze positive
clones.
2.2. Co-immunoprecipitation
Brains were homogenized in 0.32 M sucrose with protease
inhibitors cocktail (Roche), and centrifuged at 800g at 4 C for
20 min to obtain total extract. The supernatant was centrifuged
for 20 min at 54000g to pellet the membranes. Membrane pellets
were resuspended in 50 mM Tris–HCl, pH 7.5 with EDTA-free pro-
tease inhibitors. 10 mg membrane protein were diluted 1:1 in lysis
buffer (mM): 200 NaCl, 100 HEPES, pH 7.4, 10 EDTA, 100 NaF, 20
NaVO3, 2 PMSF, 1.4% Triton X-100, pre-cleared with protein G
plus/protein A Agarose (Calbiochem) or magnetic beads (New
England Biolabs) and incubated overnight at 4 C with 5 lg mouse
monoclonal anti-KV10.1 antibody (mAb33 + mAb62, [19]) or 2 lg
rabbit anti-Rabaptin-5 (Santa Cruz Biotechnology), and then mixed
with protein G/A agarose or magnetic beads in lysis buffer plus
0.2% BSA. Precipitated proteins were analyzed by Western blot
using, polyclonal anti-KV10.1 (Alomone Labs, 1:200 or 9391 [20],
1:1500), or anti-Rabaptin-5 (BD Biosciences, 1:500).
2.3. siRNA transfection
For HEK-pTracer-KV10.1 and HeLa cells, 25 nM of each 4 differ-
ent siRNA sequences against Rabaptin-5 (Hs_RABEP_1, to _4,
Qiagen) were transfected using oligofectamine for 8 h. For trans-
fection of HEK-KV10.1-BBS cells, a single Rabaptin-5 siRNA (Hs_RA-
BEP_6) was used. SH-SY5Y were transfected with 4 different siRNA
against Rabaptin-5 using nucleofection (Lonza).
2.4. Electrophysiology
Electrophysiological recordings were performed in the whole-
cell conﬁguration of the patch clamp [21] using an EPC9 ampliﬁer
and Pulse software (HEKA). Patch pipettes had resistances of
1–2 MO. The internal solution contained (mM) 100 KCl, 1 MgCl2,
45 N-methyl-D-glucamine, 10 HEPES pH 7.4, 10 1,1-bis(O-amino-
phenoxy)ethane-N,N,N0,N0-tetraacetic acid (BAPTA). The bath solu-
tion contained (mM) 160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 8 Glucose,Fig. 1. The C-terminus of KV10.1 interacts with Rabaptin-5 in a yeast-two-hybrid system
yeast retransformation and veriﬁcation of interaction on synthetic medium lacking histi
inhibitor of the HIS3 protein 3-AT.10 HEPES, pH 7.4. We used the automated capacity compensation
of the ampliﬁer to determine cell capacity and estimate series
resistance (which was compensated to 60–85%).
2.5. Microscopy
HEK293 cells were plated on glass coverslips coated with poly-
L-lysine, and transfected using lipofectamine (Roche). After 24 h,
cover slips were ﬁxed in 4% p-formaldehyde, incubated in 50 mM
NH4Cl for 15 min, washed, and mounted with Mowiol. Images
were collected with Leica SP2 confocal microscope.
For co-localization experiments, 24 h after transfection cover
slips were ﬁxed with methanol, blocked with 0.2% gelatin and
stained with anti-Rabaptin-5 (1:100).
HeLa cells were transfected with lipofectamine. Prior to live cell
imaging, the cover slips were assembled within a FCS2 closed, live-
cell chamber (Bioptechs, Butler, PA) and imaged at 37 C in Tyro-
des’s buffer containing glucose and BSA.
2.6. Recycling and surface expression of KV10.1
Surface KV10.1-BBS channels expressed in a stable HEK cell line
were labeled as described [22]. a-Bungarotoxin (BTX)-biotin
bound to surface KV10.1-BBS and also internalized in complex
was directly detected after SDS–PAGE of lysates and Western blot-
ting with streptavidin-horseradish-peroxidase (Invitrogen). To
quantify the amount of recycled molecules, a four-step pulse-chase
protocol was applied after siRNA treatment. Cells were pulsed with
BTX-biotin and allowed to internalize at 37 C; the surface popula-
tion was removed by acid wash at 4 C (these cells were used to de-
ﬁne 100% of cellular loading with BTX-biotin), chased at 37 C and
the surface population was again removed by acid wash at 37 C
[22]. At the end of the chase reaction we quantiﬁed recycling by
comparing the amount of BTX-biotin before and after removing
the surface-resident BTX-biotin molecules by acid washing.
Surface expression of KV10.1-BBS in HEK cell (transfected with
Rabaptin-5 siRNA or with scrambled) was quantiﬁed with ELISA
[22] after surface-labeling with 0.3 lM a-BTX-biotin.
3. Results
3.1. Rabaptin-5 interacts with KV10.1
A sequence coding for the C-terminus of the KV10.1 protein was
used to screen a rat brain cDNA library in yeast two-hybrid system.
Screening of 80 million transformants yielded 50 positive clones,
two of which fulﬁlled all requirements to be further characterized,
and corresponded to the C-terminus of KV10.1 itself and Rabaptin-
5 (residues 280–644) (Fig. 1). Since KV10.1 proteins form tetramers
[23], ﬁnding the C-terminus of KV10.1 itself represents a de facto
positive control.. KV10.1 showed positive interaction with itself and Rabaptin-5 in b-gal test after
dine, leucine, uracil, lysine, and tryptophan, and in the presence of the competitive
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To investigate whether Rabaptin-5 is able to interact with
KV10.1 in vivo, we performed co-immunoprecipitation experi-
ments on rat and mouse brain extracts (Fig. 2). An anti-KV10.1
antibody precipitated also Rabaptin-5 (Fig. 2A). The reverse co-
precipitation (precipitation with anti-Rabaptin-5 and detection
with anti-KV10.1) was also positive (Fig. 2B), indicating that the
interaction between KV10.1 and Rabaptin-5 is speciﬁc and occurs
in vivo. Two different anti-KV10.1 antibodies gave the same results
in both rat and mouse brains. The most prominent band in both
cases was smaller than the one detected in the total extract
(120 kDa) and corresponded to a molecular weight of approxi-
mately 100 kDa, compatible with a degradation product or with
the core glycosylated form of KV10.1 [24].
3.3. Rabaptin-5 co-localizes with KV10.1
We used live-cell imaging to more conclusively investigate co-
localization of the two proteins, since it allows for a more reliable
distinction of co-localization events that persist over time from
those that occur by chance. HeLa cells co-expressing both,
KV10.1-ECFP and Rabaptin-5-mVenus contained mobile, ﬂuores-
cent vesicles that could be distinguished based on their respective
ﬂuorescent signal (Fig. 3A–C). Some KV10.1 and Rabaptin-5 vesicles
co-localized over time, while others did not. We applied kymo-
graph (Fig. 3D) to follow these vesicles over a certain time. Here,
vesicles that contained either KV10.1 (green) or Rabaptin-5 (red),
as well as vesicles containing both (yellow) were visible. To further
illustrate this point an intensity proﬁle plot was generated (Fig. 3E)
at a particular time point (pink line in Fig. 3D) where, both co-
localized (yellow arrow in Fig. 3D and E) and non-colocalized
(either green or red arrow in Fig. 3D and E) vesicles occurred. Inter-
estingly, this particular co-localization event lasted 47.95 s, which
may be indicative of an interaction.Fig. 2. Co-immunoprecipitation of KV10.1 and Rabaptin-5. A. Membrane protein extract (
KV10.1 (mAb33/mAb62, 5 lg), and immunoblotting was performed using anti-Rabapti
protein extract (input) from rat or mouse brains were incubated with anti-Rabaptin-5 a
using polyclonal anti-KV10.1 (upper panels) or anti-Rabaptin-5 antibodies (on mouse b
control for speciﬁcity of the IP.Endosomes would be candidate structures where such an inter-
action could take place. To further examine this possibility, we co-
transfected HEK293 cells with KV10.1-ECFP (Fig. 4B) and a mutant
constitutively active Rab5-EGFP (caRab5-EGFP, kindly provided by
M. Simons, Fig. 4C). Finally, the cells were immunostained with
anti-Rabaptin-5 antibodies (Fig. 4D). caRab5 interferes with the
progression of the endocytic cycle and induces the formation of
giant early endosomes; a subpopulation of Rabaptin-5 is known
to accumulate on early endosomes under these conditions [6,11].
The EGFP signal of co-transfected HEK293 cells displayed large
multivesicular early endosomes (arrow in Fig. 4A). KV10.1 (Fig. 4B)
and Rabaptin-5 (Fig. 4D) were both recruited to the membrane of
the large vesicles (Fig. 4C), where they partially co-localized with
caRab5 (Fig. 4F; Pearson correlation coefﬁcient of 0.8 within
co-localized voxels). We interpret these data as an indication that
KV10.1 is internalized by endocytosis in a Rabaptin-5- and
Rab5-dependent manner.
3.4. Live cell imaging of HeLa cells co-expressing KV10.1 and Rab7/
Rab11
Once internalized, a protein can be directed to lysosomal degra-
dation or recycled to the membrane. Vesicles directed to degrada-
tion are positive for Rab7, while Rab11 labels those designated for
recycling. In order to identify in which of these two populations
KV10.1 is localized, we performed confocal imaging of live HeLa
cells co-transfected with KV10.1-ECFP (Fig. 5A, C and F, H) and
Rab7-EYFP (kindly provided by M. Zerial; Fig. 5B and C), and ob-
served clear co-localization events with both proteins. Rab7-EYFP
signal (expected to occur on lysosomes) appeared distinctly ring-
shaped in confocal optical sections. The KV10.1 signal was located
inside the Rab7-positive membrane structure in most of the vesi-
cles. One such vesicle was investigated in detail over time
(Fig. 5D and C). KV10.1 was localized within the Rab7-positive ves-
icle for the entire imaging session, of which 23.1 s are shown hereinput) from rat brains was subjected to immunoprecipitation using monoclonal anti-
n-5 antibody (upper panel) or anti- KV10.1 antibody (lower panel). B. Membrane
ntibody and immunoprecipitated. Proteins separated by PAGE were immunobloted
rain extract; lower panel). Incubation with 4 lg isotype control IgG was used as a
Fig. 4. KV10.1 co-localizes with Rabaptin-5 and with the GTP-bound form of Rab5. The EGFP signal of co-transfected HEK293 cells illustrates the presence of large
multivesicular early endosomes due to the caRab5-EGFP expression (C). KV10.1-ECFP (B) and Rabaptin-5 (D, anti-Rabaptin-5) are both recruited to the membrane of the large
early endosomal vesicles, where they partially co-localize with caRab5 (F,G). All three ﬂuorescence signals are presented in E. Scale bar: 5 lm.
Fig. 3. Live cell imaging of HeLa cells co-expressing KV10.1-ECFP and Rabaptin-5-mVenus. Some KV10.1-ECFP (A) and Rabaptin-5-mVenus (B) ﬂuorescent vesicles co-localize.
The white line in the lower-right corner of C represents the path along which both KV10.1 and Rabaptin-5-positive vesicles moved over time. The resulting kymograph is
shown in D. An intensity proﬁle plot (E) illustrates a particular time point (pink line) where certain vesicles co-localize (yellow arrow in D) or do not (green or red arrow in D,
E). Scale bar: 10 lm.
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proﬁles at the pink line (Fig. 5D).
Live imaging of cells co-transfected with KV10.1-ECFP (Fig. 5F
and H) and Rab11-EYFP (kindly provided by M. Zerial) (Fig. 5G
and H) showed much less co-localization of the signals (Fig. 5H).
However, we identiﬁed frequent events, where KV10.1 co-localized
with Rab11 for longer (10 s) time periods (kymograph in Fig. 5I
and proﬁle plots in Fig. 5J). Altogether this data indicates that most
of KV10.1 channels were targeted towards Rab7 positive vesicles
upon Rabaptin5/Rab5 dependent internalization, and therefore
destined to degradation.
3.5. Rabaptin-5 is involved in recycling of KV10.1 channels to the
surface
To test if Rabaptin-5 is involved in recycling of KV10.1 to the cel-
lular surface we used an engineered KV10.1-BBS, carrying an extra-
cellular minimized a-bungarotoxin binding site (BBS) [22,25]. The
insertion of the tag does not affect the electrophysiological proper-
ties of the channel.Pulse-chase experiments on BTX-biotin labeled KV10.1-BBS
(Fig. 6A) revealed that approximately 30% of the intracellular
BTX-biotin molecules detected after 1.5 h were recycled back to
the plasma membrane within 30 min in control conditions
(Fig. 6B). In contrast, silencing Rabaptin-5 reduced recycling, while
pretreatment with scrambled siRNA did not (Fig. 6B). The intrinsic
experimental variation, added to the variable efﬁcacy of siRNA
knockdown produced large deviations in values and reduced the
statistical signiﬁcance of this ﬁnding (p = 0.08). Fig. 6C demon-
strates that silencing of Rabaptin-5 was effective in the experimen-
tal period.
3.6. Rabaptin-5 affects KV10.1 functional expression in native systems
Next we compared the surface expression of KV10.1 in cells
treated with siRNA against Rabaptin-5 to that of cells treated with
a control siRNA. Surface-resident KV10.1-BBS channels were la-
beled with a-BTX-biotin and surface expression then quantiﬁed
by ELISA (Table 1). In parallel, silencing of Rabaptin-5 was quanti-
ﬁed by Western blot and densitometry. KV10.1 surface expression
Fig. 5. Live cell trafﬁcking studies of KV10.1. Trafﬁcking of ECFP-KV10.1 (A,C and F,H) was studied in live HeLa cells within the context of Rab7-EYFP (B,C) or Rab11-EYFP (G,H)
expression. KV10.1 co-localizes mostly with Rab7 (C) and to a lesser degree with Rab11 (H). Kymographs (Fig. 5D,I) were generated along a line bisecting a vesicle (white line
in C and H) and show that KV10.1 co-localizes with Rab7 during the entire imaging session and there is much less co-localization with Rab11. Intensity proﬁle plots are
presented in E and J. Scale bar: 5 lm.
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1.1 ± 0.1-fold the surface expression of cells transfected with
scrambled siRNA (which was already 1.3 ± 0.1 times larger than
untreated control) for the commonly achieved levels of Rabaptin-
5 silencing by 57 ± 15%. Silencing down to >50% of Rabaptin-5
did not alter KV10.1-BBS surface levels, while complete silencing
of Rabaptin-5 slightly increased surface expression (Table 1).
To test whether silencing of Rabaptin-5 affected channel
activity, we performed electrophysiological determinations on
several cell models where Rabaptin-5 had been silenced by siRNA
using a combination of 4 different commercially available Rabap-
tin-5 siRNAs or overexpressed. The extent of knock down was
evaluated by Western blot (Fig. 7A). Rabaptin-5 knock down
was achieved after 24 h and lasted for 48 h, therefore all measure-
ments were conducted 24–48 h after siRNA transfection. KV10.1
currents expressed in Xenopus oocytes did not change upon over-
expression of Rabaptin-5. Similarly, Rabaptin-5 knock down did
not affect KV10.1 current overexpressed in HEK293 cells (data
not shown).One could argue that massive overexpression of KV10.1 over-
comes the inﬂuence of Rabaptin-5. We therefore attempted to
measure endogenous KV10.1 potassium currents in cells with re-
duced levels of Rabaptin-5. HeLa cells express abundant endoge-
nous Rabaptin-5 and KV10.1 RNA, although KV10.1 currents are
very small. We did not detect an increase (data not shown), and
conclude that a Rabaptin-5 knock down does not lead to a massive
increase on functional KV10.1 channels on the surface of HeLa cells.
Neuroblastoma-derived SH-SY5Y cells produce large KV10.1 cur-
rents and have been used before to study this channel [26]. Since
the activation time constant of KV10.1 strongly depends on the pre-
pulse potential, we performed two consecutive depolarizations to
activate the channel from holding potentials of 120 and
60 mV respectively, and subtracted the two current traces to can-
cel out currents with prepulse-potential independent kinetics
(Fig. 7B). In this way, we observed a signiﬁcant reduction of
KV10.1 current density upon Rabaptin-5 knock down. The cell
capacity and the total outward current were not signiﬁcantly al-
tered, and therefore the fraction of outward current carried by
Fig. 6. Recycling of KV10.1 after Rabaptin-5 knock down. (A) Schematic illustration
of the protocol. (B) After loading with BTX-biotin and acid washing at 37 C, cells
were incubated on ice and used to deﬁne 100% of cellular loading with BTX-biotin.
After the chase reaction at 37 C recycling was quantiﬁed by comparing the amount
of BTX-biotin before and after acid washing. (C) Western blot analysis of Rabaptin-5
protein silencing in HEK- KV10.1-BBS cells. Equal amounts of cell protein extracts
were analyzed with mouse anti-Rabaptin-5.
Table 1
Effects of Rabaptin-5 silencing on KV10.1-BBS surface expression. KV10.1-BBS surface-
levels of siRNA treated cells were normalized to surface-levels of cells treated with
the mentioned control.
Number of
samples
Relative surface expression of KV10.1 Remaining
Rabaptin-5 [%]
siRNA-Rabaptin-5
over scrambled
Scrambled over
untreated
2 1.6 1.4 <10
2 1.1 1.3 40
1 1.0 1.3 60
3 1.2 1.4 70
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netic parameters and voltage-dependence of the KV10.1 current re-
mained unaltered upon Rabaptin-5 depletion (Fig. 7B, left). It has
been previously reported [26] that differentiation of SH-SY5Y cells
(as measured by expression of neural markers such as Neuroﬁla-
ment Y) correlates with a decrease in KV10.1 current amplitude.
To discard that Rabaptin-5 knock down induced differentiation of
SH-SY5Y cells we tested the presence of Neuroﬁlament Y by Wes-
tern blot, and could ﬁnd no evidence of differentiation.
4. Discussion
We report the interaction of KV10.1 and Rabaptin-5, an essential
and rate-limiting component of early endosomal fusion [6]. The
interaction was identiﬁed in yeast two-hybrid screening, and cor-
roborated in vivo by co-immunoprecipitation.Rabaptin-5 binds directly to the GTP-bound form of Rab5 and is
recruited to the early endosome [6] and is required for endosomal
fusion [6,27]. Different small GTPases of the Rab family are impli-
cated in the cellular transport processes of ion channels, like KV1.5
[28] or KCNQ1/KCNE1 [29].
Although it is known that KV10.1 interacts with Epsin, a protein
involved in endocytosis and cell cycle regulation, little is known
about the fate of this channel following internalization. Direct
determination of internalization and recycling of labeled channels
in a heterologous system supports these conclusions, suggesting
that 30% of the internalized molecules are recycled, and the rest
are targeted for degradation [22].
Fifty percent siRNA knock down of Rabaptin-5 does not induce
changes in the amount of KV10.1-BBS at the membrane in HEK293
cells, while a complete knock down increases surface expression in
this experimental system. A complete knock down, however, is
prone to produce artifacts in endosomal trafﬁcking and sorting.
mRNA levels of KV10.1 were not altered by manipulating Rabap-
tin-5 (determined by real time PCR, data not shown) in the pres-
ence or partial absence of Rabaptin-5 suggesting that regulation
happened on the protein level.
We did not observe any changes in KV10.1 current densities in
Xenopus oocytes, HEK293 or HeLa cells, and SH-SY5Y cells showed
a signiﬁcant decrease in current density after Rabaptin-5 knock
down. This ﬁnding is in apparent contradiction with the observa-
tion that total Rabaptin-5 knockdown produces a slight increase
in surface expression of KV10.1; however, we also show that recy-
cling to the plasma membrane is impaired by Rabaptin-5 knock-
down, and such an effect would result in a decrease in available
channels in the surface. Since we have previously reported that
internalization/degradation of KV10.1 is rather fast in SHSY5Y cells
[30], it is reasonable to interpret that a decrease in current obeys to
a decrease in recycling.
It has been reported that, upon differentiation into neuronal
lineage, SH-SY5Y cells show a down-regulation of KV10.1 currents
[26]. We could not ﬁnd any signs of differentiation upon Rabaptin-
5 knock down, and therefore we consider unlikely that differentia-
tion is the reason for a decrease in functional KV10.1 expression.
Rabaptin-5 together with Rab5 represents an essential compo-
nent of the fusion machinery of endocytic vesicles [31]. Constitu-
tively active Rab5 induced the formation of large, multivesicular
early endosomes (Fig. 4) where both KV10.1 and Rabaptin-5 were
recruited.
To determine the intracellular fate of the internalized KV10.1,
we investigated for possible co-localization with either the degra-
dation marker, Rab7 [32] or with the recycling marker, Rab11 [33].
Our results demonstrate partial localization of KV10.1 with Rab11,
while a majority of the channel was targeted to degradation, as
indicated by co-localization with Rab7. The latter result could be
conﬁrmed additionally by indirect quantiﬁcation of recycling pro-
cesses by biochemistry. Down-regulation of Rabaptin-5 strongly
inhibits recycling, indicating that Rabaptin-5 is involved in the
sorting to the recycling pathway. These results are in agreement
with the proposal that Rabaptin-5 acts as a molecular bridge be-
tween endocytosis and recycling [11].
Our observations regarding interaction of Rabaptin-5 with
KV10.1 are reminiscent of the reported interaction with GAP-43
[9], which appears important for neurite outgrowth, and is regu-
lated by Ca2+-Calmodulin, which is also an interaction partner
and modulator of KV10.1 [34–36].
In conclusion, the newly identiﬁed KV10.1 interaction partner,
Rabaptin-5, plays a role in regulation of trafﬁcking of this channel.
Biochemical and electrophysiological data in heterologously and
natively expressing cells indicate that knock down of the active
form of Rabaptin-5 reduces recycling rates of KV10.1 and leads to
a reduction of KV10.1 current density.
Fig. 7. Silencing of Rabaptin-5 impacts KV10.1 current density. (A) Western blot analysis of Rabaptin-5 protein silencing in SH-SY5Y cells. Equal amounts of cell extracts were
analyzed with mouse anti-Rabaptin-5. (B) Left: KV10.1 current amplitude was estimated by subtracting currents elicited by a depolarizing pulse to +40 mV from a
conditioning potential of 120 mV from those arising during an identical stimulus, but from a prepulse potential of 120 mV; the slower activation is characteristic of KV10.1
currents. Scale bars, 100 pA, 100 ms. Right: Subtracted traces in siRNA-treated cells were indistinguishable from control traces (representative traces scaled for comparison).
(C) Reduction of current density in SH-SY5Y cells treated with Rabaptin-5 speciﬁc siRNA.
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